Healthcare IT Today February 24, 2025
Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI Leverages Proprietary AI, Generative Computational Chemistry, and Best-in-Class Biology to Cut Drug Development Timelines and Costs, Transforming Cancer and Rare Disease Treatments
Company Raises $24.6 Million Seed Round, Co-Led by General Catalyst and Reid Hoffman with Participation from Greylock, and Establishes Partnership with Microsoft
Manas AI, a full-stack, AI-driven company focused on discovering and advancing next-generation medicines, launched today. By leveraging its proprietary AI-driven platform, its partnership with Microsoft, and a world-class team of scientists across diverse disciplines, Manas AI is uniquely positioned to disrupt the traditional model of therapeutic discovery. The company aims to significantly accelerate the process of screening, identifying, and advancing transformative medicines for cancer, autoimmune disease,...
Today's Sponsors
Today's Sponsor